| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10020921 | HBV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS10020920 | HBV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS10014897 | HBV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS10014898 | HBV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS10020940 | HBV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS10031645 | HBV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS10031646 | HBV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS10033377 | HBV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS10042368 | HBV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS30072819 | HIV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GLRA2 |
|---|---|
| DrugBank ID | DB00145 |
| Drug Name | Glycine |
| Target ID | BE0000745 |
| UniProt ID | P23416 |
| Regulation Type | ligand |
| PubMed IDs | 16847326; 17012403; 17550639 |
| Citations | Young-Pearse TL, Ivic L, Kriegstein AR, Cepko CL: Characterization of mice with targeted deletion of glycine receptor alpha 2. Mol Cell Biol. 2006 Aug;26(15):5728-34.@@Qi Z, Stephens NR, Spalding EP: Calcium entry mediated by GLR3.3, an Arabidopsis glutamate receptor with a broad agonist profile. Plant Physiol. 2006 Nov;142(3):963-71. Epub 2006 Sep 29.@@Majumdar S, Heinze L, Haverkamp S, Ivanova E, Wassle H: Glycine receptors of A-type ganglion cells of the mouse retina. Vis Neurosci. 2007 Jul-Aug;24(4):471-87. Epub 2007 May 29. |
| Groups | Approved; Nutraceutical; Vet_approved |
| Direct Classification | Alpha amino acids |
| SMILES | NCC(O)=O |
| Pathways | gamma-Glutamyltranspeptidase Deficiency; Lesch-Nyhan Syndrome (LNS); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Molybdenum Cofactor Deficiency; AICA-Ribosiduria; Purine Nucleoside Phosphorylase Deficiency; gamma-Glutamyltransferase Deficiency; Hyperprolinemia Type II; Glutamate Metabolism; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); L-Arginine:Glycine Amidinotransferase Deficiency; Hyperinsulinism-Hyperammonemia Syndrome; Congenital Bile Acid Synthesis Defect Type II; Porphyrin Metabolism; Prolidase Deficiency (PD); Glycine and Serine Metabolism; Carnitine Synthesis; Adenosine Deaminase Deficiency; Methionine Metabolism; Bile Acid Biosynthesis; Hyperprolinemia Type I; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; 27-Hydroxylase Deficiency; Sarcosine Oncometabolite Pathway; Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Ammonia Recycling |
| PharmGKB | PA449789 |
| ChEMBL | CHEMBL773 |
